Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
6.98
+0.28 (4.18%)
At close: Aug 4, 2025, 4:00 PM
7.20
+0.22 (3.15%)
After-hours: Aug 4, 2025, 7:51 PM EDT

Biodexa Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
22741323
Upgrade
Market Cap Growth
-66.49%-66.49%64.98%-67.32%-43.85%52.91%
Upgrade
Enterprise Value
1-41-3822
Upgrade
Last Close Price
6.9840.50670.0078800.00420000.00748000.00
Upgrade
PS Ratio
--14.475.0516.6449.52
Upgrade
PB Ratio
0.040.231.181.120.922.53
Upgrade
P/TBV Ratio
0.600.703.171.120.922.53
Upgrade
EV/Sales Ratio
--2.20-10.6547.35
Upgrade
Debt / Equity Ratio
0.090.090.100.200.070.04
Upgrade
Asset Turnover
--0.050.080.050.02
Upgrade
Quick Ratio
0.470.471.202.276.063.02
Upgrade
Current Ratio
1.751.751.262.476.393.10
Upgrade
Return on Equity (ROE)
-88.14%-88.14%-180.59%-112.47%-63.60%-168.89%
Upgrade
Return on Assets (ROA)
-45.41%-45.41%-52.16%-60.55%-38.48%-32.76%
Upgrade
Return on Capital (ROIC)
-81.03%-81.03%-93.86%-74.41%-48.07%-40.89%
Upgrade
Earnings Yield
-355.48%-304.90%-128.44%-216.78%-56.78%-130.65%
Upgrade
FCF Yield
-808.41%-653.01%-124.32%-201.33%-65.81%-55.99%
Upgrade
Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q